RA Capital Management's book
91 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Halda Therapeutics | Drug Discovery | ▮ | ▮ | ▮ | ▮ |
| Stipple Bio | — | ▮ | ▮ | ▮ | ▮ |
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
+ 88 more companies · all 91, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
RA Capital Management portfolio at a glance
91 portfolio companies are on record for RA Capital Management, including Halda Therapeutics, Stipple Bio and Freenome. The book leans Drug Discovery (45), Biotechnology (7) and Discovery Tools (Healthcare) (4).
66 of the 91 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 91 recorded positions
- ·The 10 latest deals — of 251 rounds
- ·Watchlist + alerts for RA Capital Management's activity